Menu
GeneBe

rs143777158

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004320.6(ATP2A1):c.839A>G(p.Asn280Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000818 in 1,614,074 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N280K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0038 ( 4 hom., cov: 32)
Exomes 𝑓: 0.00051 ( 12 hom. )

Consequence

ATP2A1
NM_004320.6 missense

Scores

5
13

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 3.24
Variant links:
Genes affected
ATP2A1 (HGNC:811): (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1) This gene encodes one of the SERCA Ca(2+)-ATPases, which are intracellular pumps located in the sarcoplasmic or endoplasmic reticula of muscle cells. This enzyme catalyzes the hydrolysis of ATP coupled with the translocation of calcium from the cytosol to the sarcoplasmic reticulum lumen, and is involved in muscular excitation and contraction. Mutations in this gene cause some autosomal recessive forms of Brody disease, characterized by increasing impairment of muscular relaxation during exercise. Alternative splicing results in three transcript variants encoding different isoforms. [provided by RefSeq, Oct 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.013020366).
BP6
Variant 16-28887633-A-G is Benign according to our data. Variant chr16-28887633-A-G is described in ClinVar as [Benign]. Clinvar id is 387826.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00381 (580/152196) while in subpopulation AFR AF= 0.013 (541/41534). AF 95% confidence interval is 0.0121. There are 4 homozygotes in gnomad4. There are 275 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ATP2A1NM_004320.6 linkuse as main transcriptc.839A>G p.Asn280Ser missense_variant 8/23 ENST00000395503.9
ATP2A1NM_173201.5 linkuse as main transcriptc.839A>G p.Asn280Ser missense_variant 8/22
ATP2A1NM_001286075.2 linkuse as main transcriptc.464A>G p.Asn155Ser missense_variant 6/21

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ATP2A1ENST00000395503.9 linkuse as main transcriptc.839A>G p.Asn280Ser missense_variant 8/231 NM_004320.6 P4O14983-2
ATP2A1ENST00000357084.7 linkuse as main transcriptc.839A>G p.Asn280Ser missense_variant 8/222 A1O14983-1
ATP2A1ENST00000536376.5 linkuse as main transcriptc.464A>G p.Asn155Ser missense_variant 6/212 O14983-3
ATP2A1ENST00000564732.1 linkuse as main transcript upstream_gene_variant 5

Frequencies

GnomAD3 genomes
AF:
0.00379
AC:
577
AN:
152078
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0130
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00335
GnomAD3 exomes
AF:
0.000951
AC:
239
AN:
251278
Hom.:
0
AF XY:
0.000692
AC XY:
94
AN XY:
135816
show subpopulations
Gnomad AFR exome
AF:
0.0118
Gnomad AMR exome
AF:
0.000463
Gnomad ASJ exome
AF:
0.000794
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000229
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000114
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
AF:
0.000507
AC:
741
AN:
1461878
Hom.:
12
Cov.:
35
AF XY:
0.000470
AC XY:
342
AN XY:
727242
show subpopulations
Gnomad4 AFR exome
AF:
0.0152
Gnomad4 AMR exome
AF:
0.000447
Gnomad4 ASJ exome
AF:
0.000957
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000139
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000459
Gnomad4 OTH exome
AF:
0.00156
GnomAD4 genome
AF:
0.00381
AC:
580
AN:
152196
Hom.:
4
Cov.:
32
AF XY:
0.00370
AC XY:
275
AN XY:
74416
show subpopulations
Gnomad4 AFR
AF:
0.0130
Gnomad4 AMR
AF:
0.00124
Gnomad4 ASJ
AF:
0.00115
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.000764
Hom.:
2
Bravo
AF:
0.00435
ESP6500AA
AF:
0.0100
AC:
44
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00119
AC:
145
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.000164
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Brody myopathy Benign:2
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Benign, criteria provided, single submitterclinical testingInvitaeJan 12, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJan 13, 2021- -
not provided Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxNov 18, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.043
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.37
Cadd
Benign
19
Dann
Benign
0.96
DEOGEN2
Uncertain
0.70
D;.;.
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.89
D;D;D
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
-0.41
N;N;.
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.9
D;D;D
REVEL
Benign
0.28
Sift
Benign
0.25
T;T;T
Sift4G
Benign
0.75
T;T;T
Polyphen
0.0010
B;B;.
Vest4
0.18
MVP
0.96
MPC
1.1
ClinPred
0.018
T
GERP RS
4.3
Varity_R
0.18
gMVP
0.67

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs143777158; hg19: chr16-28898954; API